Hemophilia treatment in 2021: Choosing the”optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians-Reference-Cited by-同舟云学术

Hemophilia treatment in 2021: Choosing the”optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians

Published:2022-03 Issue: Volume:52 Page:100890
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Hermans Cedric,Noone Declan,Benson Gary,Dolan Gerry,Eichler Hermann,Jiménez-Yuste Víctor,Königs Christoph,Lobet Sébastien,Pollard Debra,Zupančić-Šalek Silva,Mancuso Maria Elisa

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference25 articles.

1. WFH guidelines for the management of hemophilia, 3rd edition;Srivastava;Haemophilia,2020

2. Blood-induced joint disease: the pathophysiology of hemophilic arthropathy;Valentino;J Thromb Haemost,2010

3. Patient preferences in the treatment of hemophilia A: a best-worst scaling case 3 analysis;Muhlbacher;Value Health,2020

4. Addressing patient education priorities in the era of gene therapy for haemophilia: towards evidence-informed shared decision-making;Woollard;Haemophilia.,2021

5. The frequency of joint hemorrhages and procedures in nonsevere hemophilia A vs B;Soucie;Blood Adv,2018

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Normalisation of Haemostasis in Haemophilia A;EMJ Hematology;2024-07-25

2. How clinicians and persons with hemophilia may approach shared decision-making;Expert Review of Hematology;2024-05-11

3. Shared decision‐making related to treatment of haemophilia: A scoping review of influential factors and available support tools;Haemophilia;2024-04-29

4. Haemophilic arthropathy: Diagnosis, management, and aging patient considerations;Haemophilia;2024-04

5. Benefits and risks of non‐factor therapies: Redefining haemophilia treatment goals in the era of new technologies;Haemophilia;2024-03-13